The estimated Net Worth of John M Capek is at least $60.9 Milhão dollars as of 13 December 2021. John Capek owns over 149,600 units of Abbott Laboratories stock worth over $54,918,367 and over the last 18 years he sold ABT stock worth over $2,229,574. In addition, he makes $3,765,920 as Executive Vice President - Ventures at Abbott Laboratories.
Sign up
John Capek ABT stock SEC Form 4 insiders trading
John has made over 12 trades of the Abbott Laboratories stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 149,600 units of ABT stock worth $5,227,024 on 13 December 2021.
The largest trade he's ever made was exercising 149,600 units of Abbott Laboratories stock on 13 December 2021 worth over $5,227,024. On average, John trades about 16,414 units every 73 days since 2007. As of 13 December 2021 he still owns at least 470,998 units of Abbott Laboratories stock.
You can see the complete history of John Capek stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Capek biography
Dr. John M. Capek Ph.D. serves as Executive Vice President - Ventures of the Company. was Executive Vice President - Ventures of the Company. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.
What is the salary of John Capek?
As the Executive Vice President - Ventures of Abbott Laboratories, the total compensation of John Capek at Abbott Laboratories is $3,765,920. There are 7 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $27,802,800.
How old is John Capek?
John Capek is 58, he's been the Executive Vice President - Ventures of Abbott Laboratories since 2015. There are 21 older and 17 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
What's John Capek's mailing address?
John's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Insiders trading at Abbott Laboratories
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez, eJeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
What does Abbott Laboratories do?
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
What does Abbott Laboratories's logo look like?
Complete history of John Capek stock trades at Abbott Laboratories
Abbott Laboratories executives and stock owners
Abbott Laboratories executives and other stock owners filed with the SEC include:
-
Miles White,
Executive Chairman of the Board -
Robert Ford,
President, Chief Executive Officer, Director -
Lisa Earnhardt,
Executive Vice President - Medical Devices -
Hubert Allen,
Executive Vice President, General Counsel, Secretary -
Miles D. White M.B.A.,
Exec. Chairman -
Daniel Salvadori,
Executive Vice President - Nutritional Products -
Robert B. Ford,
Chairman, Pres & CEO -
John Capek,
Executive Vice President - Ventures -
Robert E. Funck Jr.,
Exec. VP of Fin. & CFO -
Hubert L. Allen,
Exec. VP, Gen. Counsel & Sec. -
Daniel Gesua Sive Salvadori,
Exec. VP and Group Pres of Established Pharmaceuticals & Nutritional Products -
John F. Ginascol,
Exec. VP of Core Diagnostics -
Robert Alpern,
Independent Director -
Sally Blount,
Independent Director -
Glenn Tilton,
Independent Director -
Samuel Scott,
Independent Director -
William Osborn,
Lead Independent Director -
Roxanne Austin,
Independent Director -
Edward Liddy,
Independent Director -
Phebe Novakovic,
Independent Director -
Nancy McKinstry,
Independent Director -
Michelle Kumbier,
Independent Director -
John Stratton,
Independent Director -
Daniel Starks,
Independent Director -
Darren McDew,
Independent Director -
Randel Woodgrift,
Senior Vice President - CRM -
Alejandro Wellisch,
Senior Vice President - Established Pharmaceuticals, Latin America -
Jared Watkin,
Senior Vice President - Diabetes Care -
Christopher Scoggins,
Senior Vice President - Rapid Diagnostics -
Michael Pederson,
Senior Vice President - Electrophysiology and Heart Failure -
Joseph Manning,
Senior Vice President - Nutrition International -
Sammy Karam,
Senior Vice President - Established Pharmaceuticals, Emerging Markets -
Michael Dale,
Senior Vice President - Structural Heart -
Jaime Contreras,
Senior Vice President - Core Laboratory Diagnostics, Commercial Operations -
Charles Brynelsen,
Senior Vice President - Abbott Vascular -
Roger Bird,
Senior Vice President - U.S. Nutrition -
Andrea Wainer,
Executive Vice President - Rapid and Molecular Diagnostics -
Andrew Lane,
Executive Vice President - Established Pharmaceuticals -
John Ginascol,
Executive Vice President - Core Diagnostics -
Mary Moreland,
Executive Vice President of Human Resources -
Robert Funck,
Chief Financial Officer, Executive Vice President - Finance -
Gregory A. Ahlberg,
Sr. VP of Core Laboratory Diagnostics & Commercial Operations -
Elaine R. Leavenworth,
Sr. VP and Chief Marketing & External Affairs Officer -
Melissa Brotz,
VP of Public Affairs & Corp. Marketing -
James E. Young,
VP and Chief Ethics & Compliance Officer -
Scott Michael Leinenweber,
VP of Investor Relations, Licensing & Acquisitions -
Sean Shrimpton,
Senior Vice President -
Deepak S. Nath,
Senior Vice President -
Brian B Yoor,
Executive Vice President & CFO -
Brian J Blaser,
Senior Vice President -
Stephen R Fussell,
Senior Vice President -
Michael J Warmuth,
Senior Vice President -
Eric S Fain,
Senior Vice President -
Sharon J Bracken,
Senior Vice President -
Michael T Rousseau,
Pres., Cardiovasc. & Neuromod. -
Richard W Ashley,
Executive Vice President -
Christopher J. Calamari,
SENIOR VICE PRESIDENT -
Julie L. Tyler,
SENIOR VICE PRESIDENT -
Jean Yves Pavee,
Senior Vice President -
W James Farrell,
Director -
Thomas C Freyman,
Senior Vice President -
Georges H. De Vos,
Senior Vice President -
Katherine C. Doyle,
Senior Vice President -
J. Scott White,
Senior Vice President -
Charles D Foltz,
Senior Vice President -
Murthy V Simhambhatla,
Senior Vice President -
Thomas G Frinzi,
Senior Vice President -
John C Landgraf,
Senior Vice President -
Greg W Linder,
Vice President -
Heather L Mason,
Senior Vice President -
Paul K Magill,
Senior Vice President -
A. David Forrest,
Senior Vice President -
H Laurance Fuller,
Director -
Carlos Alban,
Senior Vice President -
James V Mazzo,
Senior Vice President -
Holger A Liepmann,
Senior Vice President -
William D Smithburg,
Director -
Laura J Schumacher,
Senior Vice President -
David Owen,
Director -
Edward L. Michael,
Senior Vice President -
Richard A Gonzalez,
Chief Operating Officer -
Donald V Jr Patton,
Senior Vice President -
William M Daley,
Director -
Robert B Hance,
Senior Vice President -
Mary T Szela,
Senior Vice President -
Roy S Roberts,
Director -
Corlis D Murray,
Senior Vice President -
Thomas F Chen,
Senior Vice President -
Olivier Bohuon,
Senior Vice President -
James L Tyree,
Senior Vice President -
W Ann Reynolds,
Director -
Boone Jr Powell,
Director -
Edward J Fiorentino,
Senior Vice President -
Gary E Mccullough,
Senior Vice President -
Jeffrey M Leiden,
President & COO -
Jack M Greenberg,
Director -
Joseph M Nemmers,
Senior Vice President -
John R Walter,
Director -
Jeffrey R Binder,
Senior Vice President -
William G Dempsey,
Senior Vice President -
A Barry Rand,
Director -
Thomas M Wascoe,
Senior Vice President -
Christopher B Begley,
Senior Vice President -
Lance B Wyatt,
Senior Vice President -
Guillermo A Herrera,
Senior Vice President -
Lasa Jose M De,
Senior Vice President -
Fernando Mateus,
SENIOR VICE PRESIDENT -
Gregory A Ahlberg,
SENIOR VICE PRESIDENT -
John A. Jr. Mccoy,
VICE PRESIDENT -
Philip P Boudreau,
EXECUTIVE VICE PRESIDENT -
Claire Babineaux Fontenot,
-
Michael O'grady,
-
Louis H. Morrone,
EXECUTIVE VICE PRESIDENT -
Patricia Paola Gonzalez,
-
Michael F Roman,